Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study. 1986

M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008935 Mitoguazone Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase. Methylglyoxal Bis(guanylhydrazone),MGBG,Methyl-gag,NSC-32946,Methyl gag,Methylgag,NSC 32946,NSC32946
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
February 1991, Investigational new drugs,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
December 1983, Cancer treatment reports,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
August 1993, American journal of clinical oncology,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
December 1987, Cancer treatment reports,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
February 1990, Investigational new drugs,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
October 2005, Investigational new drugs,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
January 1981, Cancer treatment reports,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
February 1990, Investigational new drugs,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
May 1990, Investigational new drugs,
M S Inamasu, and N Oishi, and T T Chen, and E H Kraut, and P N Grozea, and J J Costanzi, and J D Bonnet
July 1976, Cancer,
Copied contents to your clipboard!